Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC
Clinical trial NCT05307198 · UNKNOWN
Trial details
- NCT number
- NCT05307198
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-11
- Primary completion
- 2024-04-25
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.